Simcere Pharmaceutical Group (NYSE:SCR)
CAPS Rating:
The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.
Taking it to the street
The Company is a manufacturer and supplier of branded generic pharmaceuticals in the fast growing China market.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
low valuation; great beneficiary of health reform in China; government strong support; cost-effectiveness in rolling out innovative medicine; leading performer in Chinese pharm sector